Haleon (HLN)

Sector:

Pharma and Biotech

Index:

FTSE 100

329.80p
   
  • Change Today:
      0.20p
  • 52 Week High: 353.00
  • 52 Week Low: 308.55
  • Currency: UK Pounds
  • Shares Issued: 9,132m
  • Volume: 2,301,299
  • Market Cap: £30,118m

Haleon Overview

Haleon plc is a consumer healthcare company. The Company’s product portfolio includes five categories, including oral health, vitamins, minerals, and supplements (VMS), pain relief, respiratory health, digestive health and others. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA and LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The Company's digestive health and other product offerings also include skin health and smoker’s health. Its oral health brands include Sensodyne, Polident, Parodontax, and Biotene. Its VMS brands include Centrum, Emergen-C, and Caltrate.

Key Personnel

CEO: Brian McNamara
CFO: Tobias Hestler
Independent Non-Executive Director: Dame Vivienne Cox
Independent Non-Executive Director: Asmita Dubey
Independent Non-Executive Director: Marie-Anne Aymerich
Independent Non-Executive Director: Deirdre Mahlan
Independent Non-Executive Director: Tracy Jayne Clarke
Non-Executive Chairman: Dave Lewis
Senior Independent Non-Executive Director: Manvinder Singh (Vindi) Banga
Non-Executive Dir: Bryan Supran, David Denton

Contact Details

Address: Building 5, First Floor, The Heights, Weybridge, Surrey, United Kingdom, KT13 0NY
Phone: +44 (0) 371 384 2227
Website: https://www.haleon.com/

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE 100FTSE 350FTSE All-Share
ISIN: GB00BMX86B70

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Haleon Market Data

Currency UK Pounds
Share Price 329.80p
Change Today 0.20p
% Change 0.06 %
52 Week High 353.00
52 Week Low 308.55
Volume 2,301,299
Shares Issued 9,132m
Market Cap £30,118m

Haleon Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
13.19% above the market average13.19% above the market average13.19% above the market average13.19% above the market average13.19% above the market average
77.36% above the sector average77.36% above the sector average77.36% above the sector average77.36% above the sector average77.36% above the sector average
Price Trend
7.8% below the market average7.8% below the market average7.8% below the market average7.8% below the market average7.8% below the market average
68.42% above the sector average68.42% above the sector average68.42% above the sector average68.42% above the sector average68.42% above the sector average
Income
3.01% below the market average3.01% below the market average3.01% below the market average3.01% below the market average3.01% below the market average
25% below the sector average25% below the sector average25% below the sector average25% below the sector average25% below the sector average
Growth
40.28% below the market average40.28% below the market average40.28% below the market average40.28% below the market average40.28% below the market average
40.54% below the sector average40.54% below the sector average40.54% below the sector average40.54% below the sector average40.54% below the sector average

Haleon Dividends

  Latest Previous
  Final Interim
Ex-Div 14-Mar-24 24-Aug-23
Paid 16-May-24 05-Oct-23
Amount 4.20p 1.80p

Trades for 25-Apr-2024

Time Volume / Share Price
11:02 36 @ 329.80p
11:02 53 @ 329.80p
11:01 7,220 @ 329.67p
11:01 33 @ 329.80p
11:01 41 @ 329.80p

Haleon Key Personnel

CFO Tobias Hestler
CEO Brian McNamara

Top of Page